- Filed
- Nov 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · Oct 31, 2025 | 138.64M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 141.56M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2025 | 135.9M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 129.25M sh |
| Shares Diluted | Q2 2026 · Sep 30, 2024 | 127.63M sh |
| Stock Repurchased | Q2 2026 · Sep 30, 2025 | $1.85M |
| Stock Repurchased | Q2 2026 · Sep 30, 2024 | $0 |
| Capex | Q2 2026 · Sep 30, 2025 | $1.52M |
| Capex | Q2 2026 · Sep 30, 2024 | $1.59M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2025 | $20.71M |
| Operating Cash Flow | Q2 2026 · Sep 30, 2024 | $30.47M |
| Long Term Debt | Q2 2026 · Sep 30, 2025 | $306.62M |
| Long Term Debt | Q2 2026 · Mar 31, 2025 | $338.37M |
| Short Term Debt | Q2 2026 · Sep 30, 2025 | $19.17M |
| Short Term Debt | Q2 2026 · Mar 31, 2025 | $11.59M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $75.87M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2025 | $88.05M |
| Cash And Equivalents restated | Q2 2026 · Sep 30, 2024 | $117.4M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $133.16M |
| Stockholders Equity | Q2 2026 · Jun 30, 2025 | $128.19M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $122.2M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $109.81M |
| Stockholders Equity | Q2 2026 · Jun 30, 2024 | $104.59M |
| Stockholders Equity | Q2 2026 · Mar 31, 2024 | $101.96M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $183.66M |
| Current Liabilities | Q2 2026 · Mar 31, 2025 | $169.24M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $537.59M |
| Total Liabilities | Q2 2026 · Mar 31, 2025 | $560.97M |
| Current Assets | Q2 2026 · Sep 30, 2025 | $205.62M |
| Current Assets | Q2 2026 · Mar 31, 2025 | $203.87M |
| Total Assets | Q2 2026 · Sep 30, 2025 | $670.76M |
| Total Assets | Q2 2026 · Mar 31, 2025 | $683.18M |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Diluted | Q2 2026 · Sep 30, 2025 | −$0.03 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.11 |
| Eps Diluted | Q2 2026 · Sep 30, 2024 | −$0.19 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | $0.01 |
| Eps Basic | Q2 2026 · Sep 30, 2025 | −$0.03 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.11 |
| Eps Basic | Q2 2026 · Sep 30, 2024 | −$0.19 |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $27.92M |
| Rd Expense | Q2 2026 · Sep 30, 2025 | $56.28M |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $31.29M |
| Rd Expense | Q2 2026 · Sep 30, 2024 | $63.43M |
| Net Income | Q2 2026 · Sep 30, 2025 | $767K |
| Net Income | Q2 2026 · Sep 30, 2025 | −$3.55M |
| Net Income | Q2 2026 · Jun 30, 2025 | −$4.32M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$14.54M |
| Net Income | Q2 2026 · Sep 30, 2024 | −$24.83M |
| Net Income | Q2 2026 · Jun 30, 2024 | −$10.29M |
| Operating Income | Q2 2026 · Sep 30, 2025 | $5.35M |
| Operating Income | Q2 2026 · Sep 30, 2025 | $5.91M |
| Operating Income | Q2 2026 · Sep 30, 2024 | $7.17M |
| Operating Income | Q2 2026 · Sep 30, 2024 | $5.8M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $119.34M |
| Gross Profit | Q2 2026 · Sep 30, 2025 | $239.78M |
| Gross Profit | Q2 2026 · Sep 30, 2024 | $123.18M |
| Gross Profit | Q2 2026 · Sep 30, 2024 | $244.14M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $64.76M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2025 | $125.68M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $57.82M |
| Cost Of Revenue | Q2 2026 · Sep 30, 2024 | $115.01M |
| Revenue | Q2 2026 · Sep 30, 2025 | $184.1M |
| Revenue | Q2 2026 · Sep 30, 2025 | $365.46M |
| Revenue | Q2 2026 · Sep 30, 2024 | $181M |
| Revenue | Q2 2026 · Sep 30, 2024 | $359.15M |